Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1623 of 6351
-
New hope for CIDP: modified immune protein enters human testing
Disease control Recruiting nowCIDP is an autoimmune disease. This means that the body's germ fighting (immune) system attacks itself. In CIDP, the immune system attacks the protective covering around the nerves called myelin. Over time, these nerves lose their ability to send signals to the muscles in the bod…
Phase 2 • Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Bionic breast implant aims to bring back sensation after mastectomy
Symptom relief Recruiting nowThis trial seeks to establish whether or not touch sensation can be restored to the breast via neural stimulation. Data will also be obtained to inform future feasibility (including safety), efficacy, and acceptability trials.
Sponsor: University of Chicago • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
New stent aims to prevent stroke in patients with clogged brain arteries
Disease control Recruiting nowThis clinical trial is a prospective, multicenter, single-arm study. About 300 subjects undergoing rapamycin-eluting stent implantation will be enrolled based on the inclusion and exclusion criteria. The primary endpoint is the rate of any stroke or death within 1 month. Secondar…
Sponsor: The Affiliated Hospital of Qingdao University • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New drug aims to unload the heart in lung hypertension
Disease control Recruiting nowPulmonary arterial hypertension (PAH) is a progressive disease characterized by vascular remodelling resulting in elevated pressures in the pulmonary artery (PA). This elevated pressure ultimately leads to fulminant right heart failure. Current therapeutic options are limited and…
Phase 4 • Sponsor: Amsterdam UMC, location VUmc • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Drug-resistant typhoid in kids: does a two-drug combo speed up recovery?
Disease control CompletedThis randomized controlled trial evaluates the comparative efficacy of intravenous meropenem alone versus intravenous meropenem combined with oral azithromycin in children aged 6 months to under 5 years diagnosed with blood culture-confirmed extensively drug-resistant uncomplicat…
Phase 4 • Sponsor: Sheikh Zayed Medical College • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New radiation approach aims to slow cancer in the brain and spine
Disease control OngoingThe purpose of this study is to confirm the safety and efficacy of linac based Volumetric Modulated Arc Therapy (VMAT) for craniospinal irradiation (CSI) in solid tumor cancer patients with leptomeningeal metastasis. The primary aim is to determine if linac based VMAT CSI for lep…
Sponsor: NYU Langone Health • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New drug cocktail aims to fight advanced colon cancer
Disease control Recruiting nowThis is a non-randomized, open-label, dose-escalation and dose-expansion phase I/II clinical study to evaluate the safety, tolerability, and efficacy of HCB101 in combination with Cetuximab/Bevacizumab, and FOLFOX/FOLFIRI in Advanced or Metastatic Colorectal Cancer. The trial con…
Phase 1/2 • Sponsor: Chang Gung Memorial Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Probiotic power: could a daily capsule keep athletes in the game?
Knowledge-focused CompletedThis completed external pilot study assessed the feasibility of conducting a randomised, double-blind, placebo-controlled trial of four-week multi-strain probiotic supplementation in trained athletes. Participants were allocated to receive either one probiotic capsule containing …
Sponsor: University of Ulster • Aim: Knowledge-focused
Last updated Aug 26, 2026 00:00 UTC
-
New hope for Hard-to-Treat myeloma: experimental drug tested in chinese patients
Disease control OngoingThis study will evaluate the pharmacokinetics (PK), safety, and efficacy of cevostamab in participants with relapsed or refractory (R/R) multiple myeloma (MM).
Phase 1 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Gut feeling: probiotic pill tested as long COVID remedy
Symptom relief CompletedThe goal of this clinical trial is to learn if probiotics can improve symptoms and quality of life in participants with Long COVID.
Phase 2 • Sponsor: Rush University Medical Center • Aim: Symptom relief
Last updated Aug 09, 2026 00:00 UTC
-
New CT algorithm aims to perfect heart valve sizing for tricky bicuspid patients
Disease control Recruiting nowThe goal of this study is to learn what effects the ABC Bicuspid Sizing Algorithm has on the clinical outcomes of patients with bicuspid aortic stenosis after having a transcatheter aortic valve replacement (TAVR) using the Sapien 3 valve. The main questions the study aims to ans…
Sponsor: World Health Research Inc. • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
AI outperforms traditional tests for fatty liver diagnosis?
Diagnosis CompletedThis study evaluates the accuracy of artificial intelligence (AI) models using FibroScan and clinical data to predict hepatic fibrosis in Egyptian patients with metabolic-associated fatty liver disease (MAFLD). The performance of the AI models will be compared with conventional n…
Sponsor: Tanta University • Aim: Diagnosis
Last updated Jun 27, 2026 08:06 UTC
-
Hope for rare brain disorder: new drug trial targets Jordan's syndrome
Disease control OngoingThe primary objective of this study is to assess the efficacy, safety, and tolerability of BPN14770 in participants aged 9 to 45 years with JS.
Phase 2 • Sponsor: Shionogi • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Can a cancer drug help people with HIV pause their daily meds?
Disease control OngoingThis study is designed to evaluate the safety and efficacy of pomalidomide in HIV-1-infected individuals on ART and to determine the impact of pomalidomide on virological control in people living with HIV during an analytical treatment interruption.
Phase 1/2 • Sponsor: University of Aarhus • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New pill shows promise in early lung cancer trial
Disease control Recruiting nowThis study is designed to evaluate safety and anti-tumor activity of DZD6008 in patients with advanced NSCLC with EGFR mutations.
Phase 1 • Sponsor: Dizal Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Can ditching the mask make radiation therapy more comfortable?
Symptom relief Recruiting nowAt present, open-face masks are used only in patients with claustrophobic anxiety, while all other patients are still immobilized with closed masks, thereby overlooking the need for improvement in patient comfort. Closed face masks in patients undergoing head and neck irradiation…
Sponsor: University of Zurich • Aim: Symptom relief
Last updated Aug 22, 2026 00:00 UTC
-
Tailored activity plans could boost heart health in kids with congenital heart disease
Disease control CompletedCongenital heart disease (CHD) is the most common birth defect worldwide and occurs in every 8-10 per 1000 live births in Northern Ireland. The ability to participate in physical activity (PA) is an important aspect to an individual's quality of life. The UK Chief Medical Officer…
Sponsor: University of Ulster • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Menthol gloves may soothe nerve pain caused by chemotherapy
Symptom relief OngoingThe goal of this clinical trial is to learn if menthol works to relieve chronic neuropathic pain and chemotherapy-induced peripheral neuropathy (CIPN). The primary objectives are to evaluate the safety and clinical efficacy of menthol-containing gloves and foot-covers, specifical…
Phase 2 • Sponsor: Taiwan Municipal An-Nan Hospital-China Medical University • Aim: Symptom relief
Last updated Jul 11, 2026 00:00 UTC
-
New drug ZL-1310 tested in patients with Hard-to-Treat cancers
Disease control Recruiting nowA Phase 1b/2, Open-label, Multi-center Study of ZL-1310 in Participants With Selected Solid Tumors
Phase 1/2 • Sponsor: Zai Lab (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
New PET scan could slash radiation by 100x
Diagnosis By invitation onlyThe goal of this clinical trial is to evaluate an investigational ultralow dose PET imaging technique for Parkinsonian syndromes, neuroendocrine tumors, and gliomas detection and monitoring. The main question it aims to answer is: Can the investigators optimize the timing, scan …
Phase 2 • Sponsor: Akiva Mintz • Aim: Diagnosis
Last updated Jun 27, 2026 12:23 UTC